{"transactions":[{"id":4621768,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25177,"kind":"person","name":"David Glenn","position":1,"cik":"0001606256","reported_name":"David Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2026-09-17T21:33:13.000Z","date":"2026-08-06","kind":"grant","planned":false,"acquired":true,"shares":3482,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reported securities represent restricted stock units (\"RSUs\"), each of which represents a contingent right to receive one share of Class A Common Stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"The RSUs vest in substantially equal installments on each of the first three anniversaries of August 1, 2026, subject to the Reporting Person's continued employment through the applicable vesting date."},{"field":"shares","element":"transactionShares","label":"F3","text":"This amendment to the Form 4 filed on August 10, 2026 (the \"Original Form 4\") corrects the number of RSUs granted on August 6, 2026, which was inadvertently understated in the Original Form 4 due to a calculation error. The reported amount in this amendment correctly reflects the number of RSUs granted on August 6, 2026."}],"balance_after":54959,"source":{"system":"sec-edgar","filing":"0001104659-26-108618","document":"tm2625682-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1606256/000110465926108618/tm2625682-2_4seq1.xml","form_type":"4/A","original_submission_date":"2026-08-10"}},{"id":4621766,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2026-09-17T21:32:17.000Z","date":"2026-08-06","kind":"grant","planned":false,"acquired":true,"shares":3726,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reported securities represent restricted stock units (\"RSUs\"), each of which represents a contingent right to receive one share of Class A Common Stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"The RSUs vest in substantially equal installments on each of the first three anniversaries of August 1, 2026, subject to the Reporting Person's continued employment through the applicable vesting date."},{"field":"shares","element":"transactionShares","label":"F3","text":"This amendment to the Form 4 filed on August 10, 2026 (the \"Original Form 4\") corrects the number of RSUs granted on August 6, 2026, which was inadvertently understated in the Original Form 4 due to a calculation error. The reported amount in this amendment correctly reflects the number of RSUs granted on August 6, 2026."}],"balance_after":38275,"source":{"system":"sec-edgar","filing":"0001104659-26-108617","document":"tm2625682-1_4aseq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1603584/000110465926108617/tm2625682-1_4aseq1.xml","form_type":"4/A","original_submission_date":"2026-08-10"}},{"id":692277,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25178,"kind":"person","name":"Rodriguez Patrick","position":1,"cik":"0002106109","reported_name":"Rodriguez Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Finance and Treasurer"}}],"security":"Class A Common Stock","published_at":"2026-08-10T20:19:01.000Z","date":"2026-08-06","kind":"grant","planned":false,"acquired":true,"shares":1503,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reported securities represent restricted stock units (\"RSUs\"), each of which represents a contingent right to receive one share of Class A Common Stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"The RSUs vest in substantially equal installments on each of the first three anniversaries of August 1, 2026, subject to the Reporting Person's continued employment through the applicable vesting date."}],"balance_after":1503,"source":{"system":"sec-edgar","filing":"0001104659-26-093397","document":"tm2622592-8_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926093397/tm2622592-8_4seq1.xml","form_type":"4"}},{"id":692276,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25177,"kind":"person","name":"David Glenn","position":1,"cik":"0001606256","reported_name":"David Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2026-08-10T20:18:21.000Z","date":"2026-08-06","kind":"grant","planned":false,"acquired":true,"shares":3334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reported securities represent restricted stock units (\"RSUs\"), each of which represents a contingent right to receive one share of Class A Common Stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"The RSUs vest in substantially equal installments on each of the first three anniversaries of August 1, 2026, subject to the Reporting Person's continued employment through the applicable vesting date."}],"balance_after":54811,"source":{"system":"sec-edgar","filing":"0001104659-26-093394","document":"tm2622592-7_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926093394/tm2622592-7_4seq1.xml","form_type":"4"}},{"id":692275,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2026-08-10T20:17:50.000Z","date":"2026-08-06","kind":"grant","planned":false,"acquired":true,"shares":3522,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reported securities represent restricted stock units (\"RSUs\"), each of which represents a contingent right to receive one share of Class A Common Stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"The RSUs vest in substantially equal installments on each of the first three anniversaries of August 1, 2026, subject to the Reporting Person's continued employment through the applicable vesting date."}],"balance_after":38071,"source":{"system":"sec-edgar","filing":"0001104659-26-093391","document":"tm2622592-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926093391/tm2622592-6_4seq1.xml","form_type":"4"}},{"id":692274,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25175,"kind":"person","name":"BENDHEIM Jonathan","position":1,"cik":"0001751891","reported_name":"BENDHEIM Jonathan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-08-10T20:17:15.000Z","date":"2026-08-06","kind":"grant","planned":false,"acquired":true,"shares":2716,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reported securities represent restricted stock units (\"RSUs\"), each of which represents a contingent right to receive one share of Class A Common Stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"The RSUs vest in substantially equal installments on each of the first three anniversaries of August 1, 2026, subject to the Reporting Person's continued employment through the applicable vesting date."}],"balance_after":5984,"source":{"system":"sec-edgar","filing":"0001104659-26-093388","document":"tm2622592-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926093388/tm2622592-5_4seq1.xml","form_type":"4"}},{"id":692273,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25174,"kind":"person","name":"Weinstein Judith","position":1,"cik":"0001982496","reported_name":"Weinstein Judith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Class A Common Stock","published_at":"2026-08-10T20:16:35.000Z","date":"2026-08-06","kind":"grant","planned":false,"acquired":true,"shares":2478,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reported securities represent restricted stock units (\"RSUs\"), each of which represents a contingent right to receive one share of Class A Common Stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"The RSUs vest in substantially equal installments on each of the first three anniversaries of August 1, 2026, subject to the Reporting Person's continued employment through the applicable vesting date."}],"balance_after":5453,"source":{"system":"sec-edgar","filing":"0001104659-26-093387","document":"tm2622592-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926093387/tm2622592-4_4seq1.xml","form_type":"4"}},{"id":692272,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-08-10T20:16:10.000Z","date":"2026-08-06","kind":"grant","planned":false,"acquired":true,"shares":12103,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reported securities represent restricted stock units (\"RSUs\"), each of which represents a contingent right to receive one share of Class A Common Stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"The RSUs vest in substantially equal installments on each of the first three anniversaries of August 1, 2026, subject to the Reporting Person's continued employment through the applicable vesting date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The reported securities are directly held by Jack Bendheim."}],"balance_after":26640,"source":{"system":"sec-edgar","filing":"0001104659-26-093385","document":"tm2622592-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926093385/tm2622592-3_4seq1.xml","form_type":"4"}},{"id":692271,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25171,"kind":"person","name":"Escudero Lisa Ann","position":1,"cik":"0001701415","reported_name":"Escudero Lisa Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Class A Common Stock","published_at":"2026-08-10T20:15:38.000Z","date":"2026-08-06","kind":"grant","planned":false,"acquired":true,"shares":1547,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reported securities represent restricted stock units (\"RSUs\"), each of which represents a contingent right to receive one share of Class A Common Stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"The RSUs vest in substantially equal installments on each of the first three anniversaries of August 1, 2026, subject to the Reporting Person's continued employment through the applicable vesting date."}],"balance_after":3434,"source":{"system":"sec-edgar","filing":"0001104659-26-093383","document":"tm2622592-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926093383/tm2622592-2_4seq1.xml","form_type":"4"}},{"id":692270,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25170,"kind":"person","name":"Bendheim Daniel M","position":1,"cik":"0001601576","reported_name":"Bendheim Daniel M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2026-08-10T20:15:09.000Z","date":"2026-08-06","kind":"grant","planned":false,"acquired":true,"shares":11699,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reported securities represent restricted stock units (\"RSUs\"), each of which represents a contingent right to receive one share of Class A Common Stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"The RSUs vest in substantially equal installments on each of the first three anniversaries of August 1, 2026, subject to the Reporting Person's continued employment through the applicable vesting date."}],"balance_after":15177,"source":{"system":"sec-edgar","filing":"0001104659-26-093378","document":"tm2622592-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926093378/tm2622592-1_4seq1.xml","form_type":"4"}},{"id":694547,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-08-07T00:12:30.000Z","date":"2026-08-04","kind":"other","planned":false,"acquired":false,"shares":2303,"price":36.599,"value":84287.497,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold in a broker assisted cashless exercise program to satisfy tax withholding obligations upon the receipt of Class A Common Stock in connection with the vesting and settlement of restricted stock units."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The reported securities are directly held by Jack Bendheim."}],"balance_after":14537,"source":{"system":"sec-edgar","filing":"0001104659-26-092233","document":"tm2622506-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926092233/tm2622506-6_4seq1.xml","form_type":"4"}},{"id":694546,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25171,"kind":"person","name":"Escudero Lisa Ann","position":1,"cik":"0001701415","reported_name":"Escudero Lisa Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Class A Common Stock","published_at":"2026-08-07T00:12:03.000Z","date":"2026-08-04","kind":"other","planned":false,"acquired":false,"shares":265,"price":36.599,"value":9698.735,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold in a broker assisted cashless exercise program to satisfy tax withholding obligations upon the receipt of Class A Common Stock in connection with the vesting and settlement of restricted stock units."}],"balance_after":1887,"source":{"system":"sec-edgar","filing":"0001104659-26-092232","document":"tm2622506-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926092232/tm2622506-5_4seq1.xml","form_type":"4"}},{"id":694545,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2026-08-07T00:11:26.000Z","date":"2026-08-04","kind":"other","planned":false,"acquired":false,"shares":635,"price":36.599,"value":23240.365,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold in a broker assisted cashless exercise program to satisfy tax withholding obligations upon the receipt of Class A Common Stock in connection with the vesting and settlement of restricted stock units."}],"balance_after":34549,"source":{"system":"sec-edgar","filing":"0001104659-26-092230","document":"tm2622506-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926092230/tm2622506-4_4seq1.xml","form_type":"4"}},{"id":694544,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25174,"kind":"person","name":"Weinstein Judith","position":1,"cik":"0001982496","reported_name":"Weinstein Judith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Class A Common Stock","published_at":"2026-08-07T00:10:57.000Z","date":"2026-08-04","kind":"other","planned":false,"acquired":false,"shares":472,"price":36.599,"value":17274.728,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold in a broker assisted cashless exercise program to satisfy tax withholding obligations upon the receipt of Class A Common Stock in connection with the vesting and settlement of restricted stock units."}],"balance_after":2975,"source":{"system":"sec-edgar","filing":"0001104659-26-092229","document":"tm2622506-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926092229/tm2622506-3_4seq1.xml","form_type":"4"}},{"id":694543,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25177,"kind":"person","name":"David Glenn","position":1,"cik":"0001606256","reported_name":"David Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2026-08-07T00:10:36.000Z","date":"2026-08-04","kind":"other","planned":false,"acquired":false,"shares":840,"price":36.599,"value":30743.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold in a broker assisted cashless exercise program to satisfy tax withholding obligations upon the receipt of Class A Common Stock in connection with the vesting and settlement of restricted stock units."}],"balance_after":51477,"source":{"system":"sec-edgar","filing":"0001104659-26-092228","document":"tm2622506-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926092228/tm2622506-2_4seq1.xml","form_type":"4"}},{"id":694542,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25170,"kind":"person","name":"Bendheim Daniel M","position":1,"cik":"0001601576","reported_name":"Bendheim Daniel M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2026-08-07T00:10:19.000Z","date":"2026-08-04","kind":"other","planned":false,"acquired":false,"shares":486,"price":36.599,"value":17787.114,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold in a broker assisted cashless exercise program to satisfy tax withholding obligations upon the receipt of Class A Common Stock in connection with the vesting and settlement of restricted stock units."}],"balance_after":3478,"source":{"system":"sec-edgar","filing":"0001104659-26-092227","document":"tm2622506-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926092227/tm2622506-1_4seq1.xml","form_type":"4"}},{"id":719067,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25170,"kind":"person","name":"Bendheim Daniel M","position":1,"cik":"0001601576","reported_name":"Bendheim Daniel M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Performance Stock Units","published_at":"2026-07-02T20:15:10.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance stock unit (\"PSU\") represents a contingent right to receive one share of Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The PSUs shall vest (or be forfeited), in full or in part, on June 30, 2031, subject to achievement of specified stock price performance measured as of, and subject to the Reporting Person's continued employment on, such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The PSUs shall vest (or be forfeited), in full or in part, on June 30, 2031, subject to achievement of specified stock price performance measured as of, and subject to the Reporting Person's continued employment on, such date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"The PSUs shall vest (or be forfeited), in full or in part, on June 30, 2031, subject to achievement of specified stock price performance measured as of, and subject to the Reporting Person's continued employment on, such date."}],"balance_after":300000,"derivative":{"exercise_date":"2031-06-30","expiration_date":"2031-06-30","underlying":"Class A Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001104659-26-080332","document":"tm2619107-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926080332/tm2619107-1_4seq1.xml","form_type":"4"}},{"id":755662,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":42539,"kind":"person","name":"CORCORAN E THOMAS","position":1,"cik":"0001191763","reported_name":"CORCORAN E THOMAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-06-02T22:56:16.000Z","date":"2026-05-29","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":31.77,"value":317700.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $31.66 to $31.85. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,459 shares acquired under a dividend reinvestment plan sponsored by the Reporting Person's broker."}],"balance_after":41459,"source":{"system":"sec-edgar","filing":"0001104659-26-069604","document":"tm2616591-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926069604/tm2616591-1_4seq1.xml","form_type":"4"}},{"id":788899,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-05-07T23:34:44.000Z","date":"2026-05-07","kind":"sale","planned":true,"acquired":false,"shares":2029,"price":49.1942,"value":99815.0318,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.00 to $49.50."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":56152,"source":{"system":"sec-edgar","filing":"0001104659-26-057389","document":"tm2613857-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926057389/tm2613857-1_4seq1.xml","form_type":"4"}},{"id":788898,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-05-07T23:34:44.000Z","date":"2026-05-07","kind":"sale","planned":true,"acquired":false,"shares":1149,"price":48.3074,"value":55505.2026,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.00 to $48.835."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":58181,"source":{"system":"sec-edgar","filing":"0001104659-26-057389","document":"tm2613857-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926057389/tm2613857-1_4seq1.xml","form_type":"4"}},{"id":788897,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-05-07T23:34:44.000Z","date":"2026-05-07","kind":"sale","planned":true,"acquired":false,"shares":1350,"price":47.5908,"value":64247.58,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.00 to $47.995."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":59330,"source":{"system":"sec-edgar","filing":"0001104659-26-057389","document":"tm2613857-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926057389/tm2613857-1_4seq1.xml","form_type":"4"}},{"id":788896,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-05-07T23:34:44.000Z","date":"2026-05-06","kind":"sale","planned":true,"acquired":false,"shares":1406,"price":58.1257,"value":81724.7342,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.965 to $58.31."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":60680,"source":{"system":"sec-edgar","filing":"0001104659-26-057389","document":"tm2613857-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926057389/tm2613857-1_4seq1.xml","form_type":"4"}},{"id":788895,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-05-07T23:34:44.000Z","date":"2026-05-06","kind":"sale","planned":true,"acquired":false,"shares":5634,"price":57.1752,"value":322125.0768,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.825 to $57.72."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":62086,"source":{"system":"sec-edgar","filing":"0001104659-26-057389","document":"tm2613857-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926057389/tm2613857-1_4seq1.xml","form_type":"4"}},{"id":788894,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-05-07T23:34:44.000Z","date":"2026-05-05","kind":"sale","planned":true,"acquired":false,"shares":776,"price":56.365,"value":43739.24,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.235 to $56.51."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":67720,"source":{"system":"sec-edgar","filing":"0001104659-26-057389","document":"tm2613857-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926057389/tm2613857-1_4seq1.xml","form_type":"4"}},{"id":788893,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-05-07T23:34:44.000Z","date":"2026-05-05","kind":"sale","planned":true,"acquired":false,"shares":6264,"price":55.7265,"value":349070.796,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.225 to $56.21. The Reporting Person undertakes to provide to Phibro Animal Health Corporation (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote and in footnotes 4 through 9."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":68496,"source":{"system":"sec-edgar","filing":"0001104659-26-057389","document":"tm2613857-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926057389/tm2613857-1_4seq1.xml","form_type":"4"}},{"id":797234,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-04-30T23:20:46.000Z","date":"2026-04-30","kind":"sale","planned":true,"acquired":false,"shares":1235,"price":53.3179,"value":65847.6065,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.22 to $53.39."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":74760,"source":{"system":"sec-edgar","filing":"0001104659-26-053249","document":"tm2613153-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926053249/tm2613153-1_4seq1.xml","form_type":"4"}},{"id":797233,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-04-30T23:20:46.000Z","date":"2026-04-30","kind":"sale","planned":true,"acquired":false,"shares":5805,"price":52.6473,"value":305617.5765,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.16 to $53.09."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":75995,"source":{"system":"sec-edgar","filing":"0001104659-26-053249","document":"tm2613153-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926053249/tm2613153-1_4seq1.xml","form_type":"4"}},{"id":797232,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-04-30T23:20:46.000Z","date":"2026-04-29","kind":"sale","planned":true,"acquired":false,"shares":3038,"price":53.2078,"value":161645.2964,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.00 to $53.775."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":81800,"source":{"system":"sec-edgar","filing":"0001104659-26-053249","document":"tm2613153-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926053249/tm2613153-1_4seq1.xml","form_type":"4"}},{"id":797231,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-04-30T23:20:46.000Z","date":"2026-04-29","kind":"sale","planned":true,"acquired":false,"shares":4002,"price":52.7005,"value":210907.401,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.00 to $52.97."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":84838,"source":{"system":"sec-edgar","filing":"0001104659-26-053249","document":"tm2613153-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926053249/tm2613153-1_4seq1.xml","form_type":"4"}},{"id":797230,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-04-30T23:20:46.000Z","date":"2026-04-28","kind":"sale","planned":true,"acquired":false,"shares":797,"price":56.6896,"value":45181.6112,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.53 to $56.875."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":88840,"source":{"system":"sec-edgar","filing":"0001104659-26-053249","document":"tm2613153-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926053249/tm2613153-1_4seq1.xml","form_type":"4"}},{"id":797229,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-04-30T23:20:46.000Z","date":"2026-04-28","kind":"sale","planned":true,"acquired":false,"shares":4591,"price":56.0607,"value":257374.6737,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.51 to $56.50."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":89637,"source":{"system":"sec-edgar","filing":"0001104659-26-053249","document":"tm2613153-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926053249/tm2613153-1_4seq1.xml","form_type":"4"}},{"id":797228,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-04-30T23:20:46.000Z","date":"2026-04-28","kind":"sale","planned":true,"acquired":false,"shares":1652,"price":55.096,"value":91018.592,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.51 to $55.40. The Reporting Person undertakes to provide to Phibro Animal Health Corporation (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote and in footnotes 4 through 9."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":94228,"source":{"system":"sec-edgar","filing":"0001104659-26-053249","document":"tm2613153-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926053249/tm2613153-1_4seq1.xml","form_type":"4"}},{"id":802055,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-04-23T23:30:31.000Z","date":"2026-04-23","kind":"sale","planned":true,"acquired":false,"shares":421,"price":54.5582,"value":22969.0022,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.515 to $54.61."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":95880,"source":{"system":"sec-edgar","filing":"0001104659-26-047933","document":"tm2612536-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926047933/tm2612536-1_4seq1.xml","form_type":"4"}},{"id":802054,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-04-23T23:30:31.000Z","date":"2026-04-23","kind":"sale","planned":true,"acquired":false,"shares":6619,"price":54.0651,"value":357856.8969,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.51 to $54.50."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":96301,"source":{"system":"sec-edgar","filing":"0001104659-26-047933","document":"tm2612536-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926047933/tm2612536-1_4seq1.xml","form_type":"4"}},{"id":802053,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-04-23T23:30:31.000Z","date":"2026-04-22","kind":"sale","planned":true,"acquired":false,"shares":7040,"price":54.2876,"value":382184.704,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.73 to $54.665."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":102920,"source":{"system":"sec-edgar","filing":"0001104659-26-047933","document":"tm2612536-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926047933/tm2612536-1_4seq1.xml","form_type":"4"}},{"id":802052,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-04-23T23:30:31.000Z","date":"2026-04-21","kind":"sale","planned":true,"acquired":false,"shares":5415,"price":56.1656,"value":304136.724,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.91 to $56.56."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":109960,"source":{"system":"sec-edgar","filing":"0001104659-26-047933","document":"tm2612536-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926047933/tm2612536-1_4seq1.xml","form_type":"4"}},{"id":802051,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-04-23T23:30:31.000Z","date":"2026-04-21","kind":"sale","planned":true,"acquired":false,"shares":1625,"price":55.3501,"value":89943.9125,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.905 to $55.88. The Reporting Person undertakes to provide to Phibro Animal Health Corporation (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote and in footnotes 4, 5, 6 and 7."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":115375,"source":{"system":"sec-edgar","filing":"0001104659-26-047933","document":"tm2612536-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926047933/tm2612536-1_4seq1.xml","form_type":"4"}},{"id":807540,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class B Common Stock","published_at":"2026-04-17T00:25:42.000Z","date":"2026-04-16","kind":"exercise","planned":true,"acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Class B Common Stock is convertible into Class A Common Stock at any time on a one-for-one basis, at the holder's election, and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"Class B Common Stock is convertible into Class A Common Stock at any time on a one-for-one basis, at the holder's election, and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":19496034,"derivative":{"exercise_price":0,"underlying":"Class A Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001104659-26-044506","document":"tm2611963-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926044506/tm2611963-1_4seq1.xml","form_type":"4"}},{"id":807539,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-04-17T00:25:42.000Z","date":"2026-04-16","kind":"sale","planned":true,"acquired":false,"shares":1850,"price":54.8759,"value":101520.415,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.80 to $54.985."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":117000,"source":{"system":"sec-edgar","filing":"0001104659-26-044506","document":"tm2611963-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926044506/tm2611963-1_4seq1.xml","form_type":"4"}},{"id":807538,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-04-17T00:25:42.000Z","date":"2026-04-16","kind":"sale","planned":true,"acquired":false,"shares":5190,"price":54.5552,"value":283141.488,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.80 to $54.79."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":118850,"source":{"system":"sec-edgar","filing":"0001104659-26-044506","document":"tm2611963-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926044506/tm2611963-1_4seq1.xml","form_type":"4"}},{"id":807537,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-04-17T00:25:42.000Z","date":"2026-04-16","kind":"exercise","planned":true,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F8","text":"Class B Common Stock is convertible into Class A Common Stock at any time on a one-for-one basis, at the holder's election, and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":124040,"source":{"system":"sec-edgar","filing":"0001104659-26-044506","document":"tm2611963-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926044506/tm2611963-1_4seq1.xml","form_type":"4"}},{"id":807536,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-04-17T00:25:42.000Z","date":"2026-04-15","kind":"sale","planned":true,"acquired":false,"shares":799,"price":58.1126,"value":46431.9674,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.92 to $58.22."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":24040,"source":{"system":"sec-edgar","filing":"0001104659-26-044506","document":"tm2611963-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926044506/tm2611963-1_4seq1.xml","form_type":"4"}},{"id":807535,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-04-17T00:25:42.000Z","date":"2026-04-15","kind":"sale","planned":true,"acquired":false,"shares":3618,"price":57.2099,"value":206985.4182,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.90 to $57.88."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":24839,"source":{"system":"sec-edgar","filing":"0001104659-26-044506","document":"tm2611963-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926044506/tm2611963-1_4seq1.xml","form_type":"4"}},{"id":807534,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-04-17T00:25:42.000Z","date":"2026-04-15","kind":"sale","planned":true,"acquired":false,"shares":2623,"price":56.2691,"value":147593.8493,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.87 to $56.73."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":28457,"source":{"system":"sec-edgar","filing":"0001104659-26-044506","document":"tm2611963-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926044506/tm2611963-1_4seq1.xml","form_type":"4"}},{"id":807533,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-04-17T00:25:42.000Z","date":"2026-04-14","kind":"sale","planned":true,"acquired":false,"shares":492,"price":59.6924,"value":29368.6608,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.63 to $59.83."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":31080,"source":{"system":"sec-edgar","filing":"0001104659-26-044506","document":"tm2611963-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926044506/tm2611963-1_4seq1.xml","form_type":"4"}},{"id":807532,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-04-17T00:25:42.000Z","date":"2026-04-14","kind":"sale","planned":true,"acquired":false,"shares":6548,"price":59.0338,"value":386553.3224,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.63 to $59.61. The Reporting Person undertakes to provide to Phibro Animal Health Corporation (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote and in footnotes 4, 5, 6, 7, 9 and 10."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":31572,"source":{"system":"sec-edgar","filing":"0001104659-26-044506","document":"tm2611963-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926044506/tm2611963-1_4seq1.xml","form_type":"4"}},{"id":824518,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-03-31T22:44:28.000Z","date":"2026-03-31","kind":"sale","planned":true,"acquired":false,"shares":431,"price":54.3533,"value":23426.2723,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.28 to $54.51."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":38120,"source":{"system":"sec-edgar","filing":"0001104659-26-037978","document":"tm2610803-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926037978/tm2610803-1_4seq1.xml","form_type":"4"}},{"id":824517,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-03-31T22:44:28.000Z","date":"2026-03-31","kind":"sale","planned":true,"acquired":false,"shares":6609,"price":53.8662,"value":356001.7158,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.27 to $54.26."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":38551,"source":{"system":"sec-edgar","filing":"0001104659-26-037978","document":"tm2610803-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926037978/tm2610803-1_4seq1.xml","form_type":"4"}},{"id":824516,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-03-31T22:44:28.000Z","date":"2026-03-30","kind":"sale","planned":true,"acquired":false,"shares":617,"price":54.309,"value":33508.653,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.23 to $54.385."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":45160,"source":{"system":"sec-edgar","filing":"0001104659-26-037978","document":"tm2610803-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926037978/tm2610803-1_4seq1.xml","form_type":"4"}},{"id":824515,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-03-31T22:44:28.000Z","date":"2026-03-30","kind":"sale","planned":true,"acquired":false,"shares":6423,"price":53.5415,"value":343897.0545,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.23 to $54.075. The Reporting Person undertakes to provide to Phibro Animal Health Corporation (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote and in footnotes 4, 5 and 6."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":45777,"source":{"system":"sec-edgar","filing":"0001104659-26-037978","document":"tm2610803-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926037978/tm2610803-1_4seq1.xml","form_type":"4"}},{"id":827610,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-03-27T01:19:23.000Z","date":"2026-03-26","kind":"sale","planned":true,"acquired":false,"shares":280,"price":57.1702,"value":16007.656,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.14 to $57.24."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":52200,"source":{"system":"sec-edgar","filing":"0001104659-26-035447","document":"tm269871-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926035447/tm269871-1_4seq1.xml","form_type":"4"}},{"id":827609,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-03-27T01:19:23.000Z","date":"2026-03-26","kind":"sale","planned":true,"acquired":false,"shares":6760,"price":56.7852,"value":383867.952,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.12 to $57.06."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":52480,"source":{"system":"sec-edgar","filing":"0001104659-26-035447","document":"tm269871-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926035447/tm269871-1_4seq1.xml","form_type":"4"}},{"id":827608,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-03-27T01:19:23.000Z","date":"2026-03-25","kind":"sale","planned":true,"acquired":false,"shares":552,"price":56.8584,"value":31385.8368,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.76 to $56.91."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":59240,"source":{"system":"sec-edgar","filing":"0001104659-26-035447","document":"tm269871-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926035447/tm269871-1_4seq1.xml","form_type":"4"}},{"id":827607,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-03-27T01:19:23.000Z","date":"2026-03-25","kind":"sale","planned":true,"acquired":false,"shares":4916,"price":56.0041,"value":275316.1556,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.76 to $56.745."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":59792,"source":{"system":"sec-edgar","filing":"0001104659-26-035447","document":"tm269871-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926035447/tm269871-1_4seq1.xml","form_type":"4"}},{"id":827606,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-03-27T01:19:23.000Z","date":"2026-03-25","kind":"sale","planned":true,"acquired":false,"shares":1572,"price":55.2822,"value":86903.6184,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.69 to $55.65."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":64708,"source":{"system":"sec-edgar","filing":"0001104659-26-035447","document":"tm269871-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926035447/tm269871-1_4seq1.xml","form_type":"4"}},{"id":827605,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-03-27T01:19:23.000Z","date":"2026-03-24","kind":"sale","planned":true,"acquired":false,"shares":517,"price":53.5886,"value":27705.3062,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.53 to $53.70."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":66280,"source":{"system":"sec-edgar","filing":"0001104659-26-035447","document":"tm269871-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926035447/tm269871-1_4seq1.xml","form_type":"4"}},{"id":827604,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-03-27T01:19:23.000Z","date":"2026-03-24","kind":"sale","planned":true,"acquired":false,"shares":6523,"price":52.8772,"value":344917.9756,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.44 to $53.435. The Reporting Person undertakes to provide to Phibro Animal Health Corporation (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote and in footnotes 4 through 9."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":66797,"source":{"system":"sec-edgar","filing":"0001104659-26-035447","document":"tm269871-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926035447/tm269871-1_4seq1.xml","form_type":"4"}},{"id":833915,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-03-19T23:58:21.000Z","date":"2026-03-19","kind":"sale","planned":true,"acquired":false,"shares":124,"price":53.24,"value":6601.76,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on December 11, 2025."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":73320,"source":{"system":"sec-edgar","filing":"0001104659-26-032252","document":"tm269323-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926032252/tm269323-1_4seq1.xml","form_type":"4"}},{"id":833914,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-03-19T23:58:21.000Z","date":"2026-03-19","kind":"sale","planned":true,"acquired":false,"shares":4977,"price":52.7864,"value":262717.9128,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.195 to $53.125."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":73444,"source":{"system":"sec-edgar","filing":"0001104659-26-032252","document":"tm269323-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926032252/tm269323-1_4seq1.xml","form_type":"4"}},{"id":833913,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-03-19T23:58:21.000Z","date":"2026-03-19","kind":"sale","planned":true,"acquired":false,"shares":1939,"price":51.7841,"value":100409.3699,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.19 to $52.18."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":78421,"source":{"system":"sec-edgar","filing":"0001104659-26-032252","document":"tm269323-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926032252/tm269323-1_4seq1.xml","form_type":"4"}},{"id":833912,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-03-19T23:58:21.000Z","date":"2026-03-18","kind":"sale","planned":true,"acquired":false,"shares":2651,"price":53.6436,"value":142209.1836,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.365 to $53.88."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":80360,"source":{"system":"sec-edgar","filing":"0001104659-26-032252","document":"tm269323-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926032252/tm269323-1_4seq1.xml","form_type":"4"}},{"id":833911,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-03-19T23:58:21.000Z","date":"2026-03-18","kind":"sale","planned":true,"acquired":false,"shares":3598,"price":53.0348,"value":190819.2104,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.35 to $53.295."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":83011,"source":{"system":"sec-edgar","filing":"0001104659-26-032252","document":"tm269323-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926032252/tm269323-1_4seq1.xml","form_type":"4"}},{"id":833910,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-03-19T23:58:21.000Z","date":"2026-03-18","kind":"sale","planned":true,"acquired":false,"shares":4311,"price":51.798,"value":223301.178,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.29 to $52.21."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":86609,"source":{"system":"sec-edgar","filing":"0001104659-26-032252","document":"tm269323-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926032252/tm269323-1_4seq1.xml","form_type":"4"}},{"id":833909,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-03-19T23:58:21.000Z","date":"2026-03-17","kind":"sale","planned":true,"acquired":false,"shares":5280,"price":51.659,"value":272759.52,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.26 to $52.13. The Reporting Person undertakes to provide to Phibro Animal Health Corporation (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote and in footnotes 4 through 8."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":90920,"source":{"system":"sec-edgar","filing":"0001104659-26-032252","document":"tm269323-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926032252/tm269323-1_4seq1.xml","form_type":"4"}},{"id":842421,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class B Common Stock","published_at":"2026-03-16T20:15:15.000Z","date":"2026-03-12","kind":"exercise","planned":true,"acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Class B Common Stock is convertible into Class A Common Stock at any time on a one-for-one basis, at the holder's election, and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Class B Common Stock is convertible into Class A Common Stock at any time on a one-for-one basis, at the holder's election, and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities are directly held by BFI Co., LLC (\"BFI\"). Jack Bendheim, a reporting person, director and officer of Phibro Animal Health Corporation (the \"Issuer\"), exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":19596034,"derivative":{"exercise_price":0,"underlying":"Class A Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001104659-26-028472","document":"tm268840-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926028472/tm268840-1_4seq1.xml","form_type":"4"}},{"id":842420,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-03-16T20:15:15.000Z","date":"2026-03-13","kind":"sale","planned":true,"acquired":false,"shares":5280,"price":48.91,"value":258244.8,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.48 to $49.32. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities are directly held by BFI Co., LLC (\"BFI\"). Jack Bendheim, a reporting person, director and officer of Phibro Animal Health Corporation (the \"Issuer\"), exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":96200,"source":{"system":"sec-edgar","filing":"0001104659-26-028472","document":"tm268840-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926028472/tm268840-1_4seq1.xml","form_type":"4"}},{"id":842419,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-03-16T20:15:15.000Z","date":"2026-03-12","kind":"exercise","planned":true,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Class B Common Stock is convertible into Class A Common Stock at any time on a one-for-one basis, at the holder's election, and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities are directly held by BFI Co., LLC (\"BFI\"). Jack Bendheim, a reporting person, director and officer of Phibro Animal Health Corporation (the \"Issuer\"), exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":101480,"source":{"system":"sec-edgar","filing":"0001104659-26-028472","document":"tm268840-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926028472/tm268840-1_4seq1.xml","form_type":"4"}},{"id":880255,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-27T00:09:08.000Z","date":"2026-02-26","kind":"sale","planned":true,"acquired":false,"shares":711,"price":54.2826,"value":38594.9286,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on May 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.27 to $54.355."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":1480,"source":{"system":"sec-edgar","filing":"0001104659-26-020787","document":"tm267373-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926020787/tm267373-1_4seq1.xml","form_type":"4"}},{"id":880254,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-27T00:09:08.000Z","date":"2026-02-26","kind":"sale","planned":true,"acquired":false,"shares":6329,"price":53.669,"value":339671.101,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on May 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.21 to $54.10."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":2191,"source":{"system":"sec-edgar","filing":"0001104659-26-020787","document":"tm267373-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926020787/tm267373-1_4seq1.xml","form_type":"4"}},{"id":880253,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-27T00:09:08.000Z","date":"2026-02-25","kind":"sale","planned":true,"acquired":false,"shares":7040,"price":51.7104,"value":364041.216,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on May 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.275 to $52.27."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":8520,"source":{"system":"sec-edgar","filing":"0001104659-26-020787","document":"tm267373-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926020787/tm267373-1_4seq1.xml","form_type":"4"}},{"id":880252,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-27T00:09:08.000Z","date":"2026-02-24","kind":"sale","planned":true,"acquired":false,"shares":1151,"price":51.8799,"value":59713.7649,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on May 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.80 to $52.065."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":15560,"source":{"system":"sec-edgar","filing":"0001104659-26-020787","document":"tm267373-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926020787/tm267373-1_4seq1.xml","form_type":"4"}},{"id":880251,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-27T00:09:08.000Z","date":"2026-02-24","kind":"sale","planned":true,"acquired":false,"shares":5889,"price":51.2679,"value":301916.6631,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on May 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.755 to $51.75. The Reporting Person undertakes to provide to Phibro Animal Health Corporation (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote and in footnotes 4 through 7."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":16711,"source":{"system":"sec-edgar","filing":"0001104659-26-020787","document":"tm267373-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926020787/tm267373-1_4seq1.xml","form_type":"4"}},{"id":888852,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-23T21:30:23.000Z","date":"2026-02-20","kind":"sale","planned":true,"acquired":false,"shares":397,"price":51.9644,"value":20629.8668,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on May 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.92 to $52.06."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":22600,"source":{"system":"sec-edgar","filing":"0001104659-26-018606","document":"tm266984-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926018606/tm266984-1_4seq1.xml","form_type":"4"}},{"id":888851,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-23T21:30:23.000Z","date":"2026-02-20","kind":"sale","planned":true,"acquired":false,"shares":6643,"price":51.383,"value":341337.269,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on May 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.90 to $51.89."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":22997,"source":{"system":"sec-edgar","filing":"0001104659-26-018606","document":"tm266984-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926018606/tm266984-1_4seq1.xml","form_type":"4"}},{"id":888850,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-23T21:30:23.000Z","date":"2026-02-19","kind":"sale","planned":true,"acquired":false,"shares":7040,"price":50.2568,"value":353807.872,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on May 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.965 to $50.935. The Reporting Person undertakes to provide to Phibro Animal Health Corporation (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote and in footnotes 4 and 5."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":29640,"source":{"system":"sec-edgar","filing":"0001104659-26-018606","document":"tm266984-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926018606/tm266984-1_4seq1.xml","form_type":"4"}},{"id":898190,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-19T00:40:44.000Z","date":"2026-02-18","kind":"sale","planned":true,"acquired":false,"shares":216,"price":51.9688,"value":11225.2608,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on May 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.90 to $52.05."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":36680,"source":{"system":"sec-edgar","filing":"0001104659-26-017198","document":"tm266654-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926017198/tm266654-1_4seq1.xml","form_type":"4"}},{"id":898189,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-19T00:40:44.000Z","date":"2026-02-18","kind":"sale","planned":true,"acquired":false,"shares":6824,"price":51.3774,"value":350599.3776,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on May 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.90 to $51.875."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":36896,"source":{"system":"sec-edgar","filing":"0001104659-26-017198","document":"tm266654-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926017198/tm266654-1_4seq1.xml","form_type":"4"}},{"id":898188,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-19T00:40:44.000Z","date":"2026-02-13","kind":"sale","planned":true,"acquired":false,"shares":7040,"price":51.9633,"value":365821.632,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on May 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.61 to $52.345. The Reporting Person undertakes to provide to Phibro Animal Health Corporation (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote and in footnotes 4 and 5."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":43720,"source":{"system":"sec-edgar","filing":"0001104659-26-017198","document":"tm266654-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926017198/tm266654-1_4seq1.xml","form_type":"4"}},{"id":910530,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-11T23:27:20.000Z","date":"2026-02-11","kind":"sale","planned":true,"acquired":false,"shares":234,"price":52.2074,"value":12216.5316,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on May 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.205 to $52.21."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":50760,"source":{"system":"sec-edgar","filing":"0001104659-26-013602","document":"tm265965-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926013602/tm265965-1_4seq1.xml","form_type":"4"}},{"id":910529,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-11T23:27:20.000Z","date":"2026-02-11","kind":"sale","planned":true,"acquired":false,"shares":13950,"price":51.6107,"value":719969.265,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on May 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.11 to $52.04."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":50994,"source":{"system":"sec-edgar","filing":"0001104659-26-013602","document":"tm265965-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926013602/tm265965-1_4seq1.xml","form_type":"4"}},{"id":910528,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-11T23:27:20.000Z","date":"2026-02-10","kind":"sale","planned":true,"acquired":false,"shares":7020,"price":52.173,"value":366254.46,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on May 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.10 to $52.30."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":64944,"source":{"system":"sec-edgar","filing":"0001104659-26-013602","document":"tm265965-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926013602/tm265965-1_4seq1.xml","form_type":"4"}},{"id":910527,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-11T23:27:20.000Z","date":"2026-02-10","kind":"sale","planned":true,"acquired":false,"shares":50994,"price":51.7565,"value":2639270.961,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on May 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.10 to $52.09. The Reporting Person undertakes to provide to Phibro Animal Health Corporation (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote and in footnotes 4, 5 and 6."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":71964,"source":{"system":"sec-edgar","filing":"0001104659-26-013602","document":"tm265965-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926013602/tm265965-1_4seq1.xml","form_type":"4"}},{"id":910526,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25177,"kind":"person","name":"David Glenn","position":1,"cik":"0001606256","reported_name":"David Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-11T21:15:07.000Z","date":"2026-02-09","kind":"exercise","planned":false,"acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Shares were issued in settlement of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On February 9, 2024 (the \"Grant Date\"), the reporting person was granted 300,000 RSUs pursuant to the Issuer's 2008 Incentive Plan and an RSU award agreement (the \"Award Agreement\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Pursuant to the Award Agreement, (i) 150,000 RSUs are subject to time vesting (collectively, the \"Time Vesting RSUs\") and vest in equal installments on each of the first five anniversaries of the Grant Date, subject to continued service through each such vesting date, and (ii) 150,000 RSUs are subject to performance vesting (collectively, the \"Performance Vesting RSUs\") and vest (with linear interpolation to apply for achievement between increments) based upon achievement of the arithmetic average of the Issuer's closing stock price per share for each trading day in the 90-calendar day period ending five years from the Grant Date, from $20 to $60 and above, subject to Mr. David's continued employment on such date. Time Vesting RSUs and Performance Vesting RSUs, in each case, are subject to earlier vesting upon certain qualifying termination events."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On February 9, 2024 (the \"Grant Date\"), the reporting person was granted 300,000 RSUs pursuant to the Issuer's 2008 Incentive Plan and an RSU award agreement (the \"Award Agreement\")."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Pursuant to the Award Agreement, (i) 150,000 RSUs are subject to time vesting (collectively, the \"Time Vesting RSUs\") and vest in equal installments on each of the first five anniversaries of the Grant Date, subject to continued service through each such vesting date, and (ii) 150,000 RSUs are subject to performance vesting (collectively, the \"Performance Vesting RSUs\") and vest (with linear interpolation to apply for achievement between increments) based upon achievement of the arithmetic average of the Issuer's closing stock price per share for each trading day in the 90-calendar day period ending five years from the Grant Date, from $20 to $60 and above, subject to Mr. David's continued employment on such date. Time Vesting RSUs and Performance Vesting RSUs, in each case, are subject to earlier vesting upon certain qualifying termination events."}],"balance_after":240000,"derivative":{"underlying":"Class A Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001104659-26-013378","document":"tm265965-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926013378/tm265965-2_4seq1.xml","form_type":"4"}},{"id":910525,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25177,"kind":"person","name":"David Glenn","position":1,"cik":"0001606256","reported_name":"David Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2026-02-11T21:15:07.000Z","date":"2026-02-11","kind":"other","planned":false,"acquired":false,"shares":12528,"price":51.625,"value":646758.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares sold in a broker assisted cashless exercise program to satisfy tax withholding obligations upon the receipt of Class A Common Stock in connection with the vesting and settlement of the RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.54 to $52.03. The reporting person undertakes to provide to Phibro Animal Health Corporation (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":52317,"source":{"system":"sec-edgar","filing":"0001104659-26-013378","document":"tm265965-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926013378/tm265965-2_4seq1.xml","form_type":"4"}},{"id":910524,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25177,"kind":"person","name":"David Glenn","position":1,"cik":"0001606256","reported_name":"David Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2026-02-11T21:15:07.000Z","date":"2026-02-09","kind":"exercise","planned":false,"acquired":true,"shares":30000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares were issued in settlement of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Class A Common Stock."}],"balance_after":64845,"source":{"system":"sec-edgar","filing":"0001104659-26-013378","document":"tm265965-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926013378/tm265965-2_4seq1.xml","form_type":"4"}},{"id":914900,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class B Common Stock","published_at":"2026-02-09T21:15:17.000Z","date":"2026-02-05","kind":"exercise","planned":true,"acquired":false,"shares":185000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Class B Common Stock is convertible into Class A Common Stock at any time on a one-for-one basis, at the holder's election, and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Class B Common Stock is convertible into Class A Common Stock at any time on a one-for-one basis, at the holder's election, and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities are directly held by BFI Co., LLC (\"BFI\"). Jack Bendheim, a reporting person, director and officer of Phibro Animal Health Corporation (the \"Issuer\"), exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":19696034,"derivative":{"exercise_price":0,"underlying":"Class A Common Stock","underlying_shares":185000},"source":{"system":"sec-edgar","filing":"0001104659-26-012073","document":"tm265586-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926012073/tm265586-1_4seq1.xml","form_type":"4"}},{"id":914899,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-09T21:15:17.000Z","date":"2026-02-05","kind":"sale","planned":true,"acquired":false,"shares":19138,"price":49.5718,"value":948705.1084,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI on May 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.18 to $50.01."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities are directly held by BFI Co., LLC (\"BFI\"). Jack Bendheim, a reporting person, director and officer of Phibro Animal Health Corporation (the \"Issuer\"), exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":122958,"source":{"system":"sec-edgar","filing":"0001104659-26-012073","document":"tm265586-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926012073/tm265586-1_4seq1.xml","form_type":"4"}},{"id":914898,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-09T21:15:17.000Z","date":"2026-02-05","kind":"sale","planned":true,"acquired":false,"shares":46275,"price":48.653,"value":2251417.575,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI on May 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.175 to $49.17."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities are directly held by BFI Co., LLC (\"BFI\"). Jack Bendheim, a reporting person, director and officer of Phibro Animal Health Corporation (the \"Issuer\"), exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":142096,"source":{"system":"sec-edgar","filing":"0001104659-26-012073","document":"tm265586-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926012073/tm265586-1_4seq1.xml","form_type":"4"}},{"id":914897,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-09T21:15:17.000Z","date":"2026-02-05","kind":"sale","planned":true,"acquired":false,"shares":38209,"price":47.9055,"value":1830421.2495,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI on May 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.17 to $48.17."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities are directly held by BFI Co., LLC (\"BFI\"). Jack Bendheim, a reporting person, director and officer of Phibro Animal Health Corporation (the \"Issuer\"), exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":188371,"source":{"system":"sec-edgar","filing":"0001104659-26-012073","document":"tm265586-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926012073/tm265586-1_4seq1.xml","form_type":"4"}},{"id":914896,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-09T21:15:17.000Z","date":"2026-02-05","kind":"sale","planned":true,"acquired":false,"shares":3171,"price":46.6816,"value":148027.3536,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI on May 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.10 to $47.08."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities are directly held by BFI Co., LLC (\"BFI\"). Jack Bendheim, a reporting person, director and officer of Phibro Animal Health Corporation (the \"Issuer\"), exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":226580,"source":{"system":"sec-edgar","filing":"0001104659-26-012073","document":"tm265586-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926012073/tm265586-1_4seq1.xml","form_type":"4"}},{"id":914895,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-09T21:15:17.000Z","date":"2026-02-05","kind":"sale","planned":true,"acquired":false,"shares":3640,"price":45.4242,"value":165344.088,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI on May 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.04 to $46.02."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities are directly held by BFI Co., LLC (\"BFI\"). Jack Bendheim, a reporting person, director and officer of Phibro Animal Health Corporation (the \"Issuer\"), exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":229751,"source":{"system":"sec-edgar","filing":"0001104659-26-012073","document":"tm265586-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926012073/tm265586-1_4seq1.xml","form_type":"4"}},{"id":914894,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-09T21:15:17.000Z","date":"2026-02-05","kind":"sale","planned":true,"acquired":false,"shares":409,"price":44.4688,"value":18187.7392,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI on May 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.035 to $44.73. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote and in footnotes 5 through 9."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities are directly held by BFI Co., LLC (\"BFI\"). Jack Bendheim, a reporting person, director and officer of Phibro Animal Health Corporation (the \"Issuer\"), exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":233391,"source":{"system":"sec-edgar","filing":"0001104659-26-012073","document":"tm265586-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926012073/tm265586-1_4seq1.xml","form_type":"4"}},{"id":914893,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-09T21:15:17.000Z","date":"2026-02-05","kind":"exercise","planned":true,"acquired":true,"shares":185000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Class B Common Stock is convertible into Class A Common Stock at any time on a one-for-one basis, at the holder's election, and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities are directly held by BFI Co., LLC (\"BFI\"). Jack Bendheim, a reporting person, director and officer of Phibro Animal Health Corporation (the \"Issuer\"), exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":233800,"source":{"system":"sec-edgar","filing":"0001104659-26-012073","document":"tm265586-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926012073/tm265586-1_4seq1.xml","form_type":"4"}},{"id":918155,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class B Common Stock","published_at":"2026-02-06T00:22:29.000Z","date":"2026-02-04","kind":"exercise","planned":true,"acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Class B Common Stock is convertible into Class A Common Stock at any time on a one-for-one basis, at the holder's election, and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Class B Common Stock is convertible into Class A Common Stock at any time on a one-for-one basis, at the holder's election, and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":19881034,"derivative":{"exercise_price":0,"underlying":"Class A Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001104659-26-011113","document":"tm265335-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926011113/tm265335-1_4seq1.xml","form_type":"4"}},{"id":918154,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-06T00:22:29.000Z","date":"2026-02-04","kind":"sale","planned":true,"acquired":false,"shares":3520,"price":41.1544,"value":144863.488,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on May 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.535 to $41.52."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":48800,"source":{"system":"sec-edgar","filing":"0001104659-26-011113","document":"tm265335-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926011113/tm265335-1_4seq1.xml","form_type":"4"}},{"id":918153,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-06T00:22:29.000Z","date":"2026-02-04","kind":"exercise","planned":true,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Class B Common Stock is convertible into Class A Common Stock at any time on a one-for-one basis, at the holder's election, and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":52320,"source":{"system":"sec-edgar","filing":"0001104659-26-011113","document":"tm265335-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926011113/tm265335-1_4seq1.xml","form_type":"4"}},{"id":918152,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-06T00:22:29.000Z","date":"2026-02-03","kind":"sale","planned":true,"acquired":false,"shares":2971,"price":41.9667,"value":124683.0657,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on May 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.70 to $42.62."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":22320,"source":{"system":"sec-edgar","filing":"0001104659-26-011113","document":"tm265335-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926011113/tm265335-1_4seq1.xml","form_type":"4"}},{"id":918151,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-06T00:22:29.000Z","date":"2026-02-03","kind":"sale","planned":true,"acquired":false,"shares":6689,"price":41.2508,"value":275926.6012,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on May 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.69 to $41.68. The Reporting Person undertakes to provide to Phibro Animal Health Corporation (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote and in footnotes 4 and 6."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":25291,"source":{"system":"sec-edgar","filing":"0001104659-26-011113","document":"tm265335-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926011113/tm265335-1_4seq1.xml","form_type":"4"}},{"id":925696,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-02T21:15:18.000Z","date":"2026-01-30","kind":"sale","planned":true,"acquired":false,"shares":6693,"price":40.0941,"value":268349.8113,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on May 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.365."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":31980,"source":{"system":"sec-edgar","filing":"0001104659-26-009210","document":"tm264637-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926009210/tm264637-1_4seq1.xml","form_type":"4"}},{"id":925695,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-02T21:15:18.000Z","date":"2026-01-29","kind":"sale","planned":true,"acquired":false,"shares":6772,"price":40.1192,"value":271687.2224,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on May 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.475. The Reporting Person undertakes to provide to Phibro Animal Health Corporation (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote and in footnote 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":38673,"source":{"system":"sec-edgar","filing":"0001104659-26-009210","document":"tm264637-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926009210/tm264637-1_4seq1.xml","form_type":"4"}}],"next_cursor":"2026-02-02T21:15:18.000000Z,925695"}